EMEA-002081-PIP01-16
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0125/2017
|
| PIP number |
EMEA-002081-PIP01-16
|
| Pharmaceutical form(s) |
Modified-release tablet
|
| Condition(s) / indication(s) |
Treatment of hypertension
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Pharmaceutical Works Polpharma SA
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|